FDA Approved: FOSAPREPITANT DIMEGLUMINE — Supplemental Application (Eugia US LLC)

View source ↗

Summary

The FDA approved a supplemental application for fosaprepitant dimeglumine (generic) from Eugia US LLC under ANDA210625.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• fosaprepitant dimeglumine (fosaprepitant dimeglumine)

Snippet

SUPPL AP for FOSAPREPITANT DIMEGLUMINE (FOSAPREPITANT DIMEGLUMINE)